218 related articles for article (PubMed ID: 10747877)
21. Subtype-specific regulation of receptor internalization and recycling by the carboxyl-terminal domains of the human A1 and rat A3 adenosine receptors: consequences for agonist-stimulated translocation of arrestin3.
Ferguson G; Watterson KR; Palmer TM
Biochemistry; 2002 Dec; 41(50):14748-61. PubMed ID: 12475223
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.
Kumar P; Lau CS; Mathur M; Wang P; DeFea KA
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C346-57. PubMed ID: 17442737
[TBL] [Abstract][Full Text] [Related]
23. Agonist-mediated endocytosis of rat somatostatin receptor subtype 3 involves beta-arrestin and clathrin coated vesicles.
Kreuzer OJ; Krisch B; Déry O; Bunnett NW; Meyerhof W
J Neuroendocrinol; 2001 Mar; 13(3):279-87. PubMed ID: 11207943
[TBL] [Abstract][Full Text] [Related]
24. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
[TBL] [Abstract][Full Text] [Related]
25. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
26. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.
Vaughan DJ; Millman EE; Godines V; Friedman J; Tran TM; Dai W; Knoll BJ; Clark RB; Moore RH
J Biol Chem; 2006 Mar; 281(11):7684-92. PubMed ID: 16407241
[TBL] [Abstract][Full Text] [Related]
27. beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation.
Paing MM; Stutts AB; Kohout TA; Lefkowitz RJ; Trejo J
J Biol Chem; 2002 Jan; 277(2):1292-300. PubMed ID: 11694535
[TBL] [Abstract][Full Text] [Related]
28. Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways.
Maguire JJ; Kuc RE; Pell VR; Green A; Brown M; Kumar S; Wehrman T; Quinn E; Davenport AP
Life Sci; 2012 Oct; 91(13-14):544-9. PubMed ID: 22480514
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors.
Pippig S; Andexinger S; Daniel K; Puzicha M; Caron MG; Lefkowitz RJ; Lohse MJ
J Biol Chem; 1993 Feb; 268(5):3201-8. PubMed ID: 8381421
[TBL] [Abstract][Full Text] [Related]
30. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
Shinyama H; Masuzaki H; Fang H; Flier JS
Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity.
Freedman NJ; Ament AS; Oppermann M; Stoffel RH; Exum ST; Lefkowitz RJ
J Biol Chem; 1997 Jul; 272(28):17734-43. PubMed ID: 9211925
[TBL] [Abstract][Full Text] [Related]
32. Agonist-dependent internalization of the angiotensin II type one receptor (AT1): role of C-terminus phosphorylation in recruitment of beta-arrestins.
Kule CE; Karoor V; Day JN; Thomas WG; Baker KM; Dinh D; Acker KA; Booz GW
Regul Pept; 2004 Aug; 120(1-3):141-8. PubMed ID: 15177932
[TBL] [Abstract][Full Text] [Related]
33. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
Estall JL; Koehler JA; Yusta B; Drucker DJ
J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
[TBL] [Abstract][Full Text] [Related]
34. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
[TBL] [Abstract][Full Text] [Related]
35. Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2.
Hanyaloglu AC; Seeber RM; Kohout TA; Lefkowitz RJ; Eidne KA
J Biol Chem; 2002 Dec; 277(52):50422-30. PubMed ID: 12393857
[TBL] [Abstract][Full Text] [Related]
36. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2003 Apr; 278(16):14498-506. PubMed ID: 12574160
[TBL] [Abstract][Full Text] [Related]
37. Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization.
Ouedraogo M; Lecat S; Rochdi MD; Hachet-Haas M; Matthes H; Gicquiaux H; Verrier S; Gaire M; Glasser N; Mély Y; Takeda K; Bouvier M; Galzi JL; Bucher B
Traffic; 2008 Mar; 9(3):305-24. PubMed ID: 18088318
[TBL] [Abstract][Full Text] [Related]
38. Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization features.
Mhaouty-Kodja S; Barak LS; Scheer A; Abuin L; Diviani D; Caron MG; Cotecchia S
Mol Pharmacol; 1999 Feb; 55(2):339-47. PubMed ID: 9927627
[TBL] [Abstract][Full Text] [Related]
39. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.
Oakley RH; Laporte SA; Holt JA; Barak LS; Caron MG
J Biol Chem; 2001 Jun; 276(22):19452-60. PubMed ID: 11279203
[TBL] [Abstract][Full Text] [Related]
40. Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor.
Kim SJ; Kim MY; Lee EJ; Ahn YS; Baik JH
Mol Endocrinol; 2004 Mar; 18(3):640-52. PubMed ID: 14684845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
